Enterprise Trust & Investment’s Wells Fargo WFC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1.53M Buy
39,010
+35
+0.1% +$1.54K 0.64% 47
2022
Q1
$1.89M Sell
38,975
-1,200
-3% -$64.2K 0.68% 41
2021
Q4
$1.93M Sell
40,175
-600
-1% -$29.5K 0.67% 43
2021
Q3
$1.89M Sell
40,775
-200
-0.5% -$9.26K 0.77% 40
2021
Q2
$1.86M Sell
40,975
-250
-0.6% -$11.2K 0.76% 38
2021
Q1
$1.61M Sell
41,225
-600
-1% -$21.2K 0.72% 40
2020
Q4
$1.42M Sell
41,825
-350
-0.8% -$9.06K 0.67% 42
2020
Q3
$992K Sell
42,175
-10,600
-20% -$261K 0.55% 43
2020
Q2
$1.35M Sell
52,775
-800
-1% -$21.9K 0.81% 35
2020
Q1
$1.54M Sell
53,575
-525
-1% -$22.3K 1.08% 31
2019
Q4
$2.91M Buy
54,100
+15,000
+38% +$786K 1.62% 20
2019
Q3
$1.97M Buy
39,100
+9,000
+30% +$424K 1.21% 33
2019
Q2
$1.42M Buy
+30,100
New +$1.41M 0.88% 36

Other funds holding WFC

Enterprise Trust & Investment's WFC Position: Q2 2022 in Review

Enterprise Trust & Investment increased its Wells Fargo (WFC) stake by 0.09% in Q2 2022, buying an estimated $1.54K and bringing the position to 39,010 shares worth $1.53M. The position accounts for 0.64% of the portfolio, ranked #47.

Enterprise Trust & Investment first reported a position in WFC in Q2 2019 and has held it in 13 quarters since. The position peaked at $2.91M in Q4 2019. 1,993 funds tracked by Wall St. Rank hold WFC as of Q2 2022.

  • Enterprise Trust & Investment held 39,010 shares of Wells Fargo worth $1.53M as of Q2 2022.
  • Enterprise Trust & Investment bought 35 Wells Fargo shares in Q2 2022, an estimated $1.54K.
  • Wells Fargo made up 0.64% of Enterprise Trust & Investment's portfolio in Q2 2022, its #47 holding.
  • Enterprise Trust & Investment first reported a position in Wells Fargo in Q2 2019 and has held it in 13 quarters since.
  • Enterprise Trust & Investment's Wells Fargo position peaked at $2.91M in Q4 2019.
  • 1,993 funds tracked by Wall St. Rank held Wells Fargo as of Q2 2022.

Based on Enterprise Trust & Investment's 13F filing for Q2 2022, filed 22 Jul 2022.